Hutchison China Meditech Limited Director's Share Dealing (8020R)

TIDMHCM

RNS Number : 8020R

Hutchison China Meditech Limited

14 December 2016

Director's Share Dealing

London: Wednesday, December 14, 2016: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) has received notification that Mr Simon To, Executive Director and Chairman, purchased a total of 52,161 American Depositary Shares of the Company ("ADSs", each representing one half of one ordinary share of US$1.00 each in the capital of Chi-Med ("Ordinary Share")) at an average price of US$14.18 per ADS on December 9, 2016, December 12, 2016 and December 13, 2016.

Following the above purchase of 52,161 ADSs, Mr To is interested in 52,161 ADSs and 180,000 Ordinary Shares (including the holding of 78,000 Ordinary Shares in a family trust of which his family members are the beneficiaries), representing approximately 0.34% of the current issued share capital of Chi-Med.

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 
 1     Details of the person discharging managerial responsibilities/person closely associated 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Name                                                     Mr Simon To 
----  -------------------------------------------------------  ------------------------------------------------------- 
 2     Reason for the notification 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Position/status                                          Executive Director and Chairman 
----  -------------------------------------------------------  ------------------------------------------------------- 
  b)    Initial notification/Amendment                           Initial notification 
----  -------------------------------------------------------  ------------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, auction platform, auctioneer 
        or auction monitor 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Name                                                     Hutchison China MediTech Limited 
----  -------------------------------------------------------  ------------------------------------------------------- 
  b)    LEI                                                      N/A 
----  -------------------------------------------------------  ------------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Description of the financial instrument, type of         ADS each representing one half of one Ordinary Share 
        instrument                                               of US$1.00 
        Identification code                                      ADS ISIN: US44842L1035 
----  -------------------------------------------------------  ------------------------------------------------------- 
  b)    Nature of the transaction                                Acquisition of ADSs 
----  -------------------------------------------------------  ------------------------------------------------------- 
  c)    Price(s) and volume(s)                                    Price(s)    Volume(s) 
                                                                  ----------  ---------- 
                                                                   US$14.05     10,000 
                                                                  ----------  ---------- 
----  -------------------------------------------------------  ------------------------------------------------------- 
  d)    Aggregated information                                   N/A 
         -  Aggregated volume 
         -  Price 
----  -------------------------------------------------------  ------------------------------------------------------- 
  e)    Date of the transaction                                  2016-12-09 
----  -------------------------------------------------------  ------------------------------------------------------- 
  f)    Place of the transaction                                 Nasdaq Stock Market 
----  -------------------------------------------------------  ------------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Description of the financial instrument, type of         ADS each representing one half of one Ordinary Share 
        instrument                                               of US$1.00 
        Identification code                                      ADS ISIN: US44842L1035 
----  -------------------------------------------------------  ------------------------------------------------------- 
  b)    Nature of the transaction                                Acquisition of ADSs 
----  -------------------------------------------------------  ------------------------------------------------------- 
  c)    Price(s) and volume(s)                                    Price(s)    Volume(s) 
                                                                  ----------  ---------- 
                                                                   US$14.12     30,000 
                                                                  ----------  ---------- 
----  -------------------------------------------------------  ------------------------------------------------------- 
  d)    Aggregated information                                   N/A 
         -  Aggregated volume 
         -  Price 
----  -------------------------------------------------------  ------------------------------------------------------- 
  e)    Date of the transaction                                  2016-12-12 
----  -------------------------------------------------------  ------------------------------------------------------- 
  f)    Place of the transaction                                 Nasdaq Stock Market 
----  -------------------------------------------------------  ------------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Description of the financial instrument, type of         ADS each representing one half of one Ordinary Share 
        instrument                                               of US$1.00 
        Identification code                                      ADS ISIN: US44842L1035 
----  -------------------------------------------------------  ------------------------------------------------------- 
  b)    Nature of the transaction                                Acquisition of ADSs 
----  -------------------------------------------------------  ------------------------------------------------------- 
  c)    Price(s) and volume(s)                                    Price(s)    Volume(s) 
                                                                  ----------  ---------- 
                                                                   US$14.43     12,161 
                                                                  ----------  ---------- 
----  -------------------------------------------------------  ------------------------------------------------------- 
  d)    Aggregated information                                   N/A 
         -  Aggregated volume 
         -  Price 
----  -------------------------------------------------------  ------------------------------------------------------- 
  e)    Date of the transaction                                  2016-12-13 
----  -------------------------------------------------------  ------------------------------------------------------- 
  f)    Place of the transaction                                 Nasdaq Stock Market 
----  -------------------------------------------------------  ------------------------------------------------------- 
 

About Chi-Med

Chi-Med is an innovative biopharmaceutical company which researches, develops, manufactures and sells pharmaceuticals and healthcare products. Its Innovation Platform, Hutchison MediPharma Limited, focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures, markets, and distributes prescription drugs and consumer health products in China.

Chi-Med is majority owned by the multinational conglomerate CK Hutchison Holdings Limited (SEHK: 0001). For more information, please visit: www.chi-med.com.

Contacts

 
Investor Enquiries 
Christian Hogg, CEO               [phone] 
 
International Media Enquiries 
Anthony Carlisle,                 [phone] (Mobile)   [e-mail] 
 Citigate Dewe Rogerson 
 
U.S. Based Media Enquiries 
Brad Miles, BMC Communications    [phone] (Mobile)  [e-mail] 
 
Susan Duffy, BMC Communications   [phone] (Mobile)  [e-mail] 
 
Investor Relations 
Matt Beck, The Trout Group        [phone] (Mobile)  [e-mail] 
 
David Dible,                      [phone] (Mobile)   [e-mail] 
 Citigate Dewe Rogerson 
 
Panmure Gordon (UK) Limited 
Richard Gray / Andrew Potts       [phone] 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLIFLDFVLSLIR

(END) Dow Jones Newswires

December 14, 2016 02:14 ET (07:14 GMT)